Cigna Group (NYSE:CI) Issues FY 2026 Earnings Guidance

Posted by Stanley Muller on Sep 30th, 2026

Cigna Group (NYSE:CI – Get Free Report) updated its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 30.450- for the period, compared to the consensus EPS estimate of 30.510. The company issued revenue guidance of $280.0 billion-$280.0 billion, compared to the consensus revenue estimate of $287.2 billion.

Analyst Ratings Changes

A number of research firms have recently weighed in on CI. Guggenheim raised their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Mizuho raised their price objective on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 target price on shares of Cigna Group in a research report on Tuesday, June 16th. Sanford C. Bernstein boosted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Finally, Wells Fargo & Company lifted their target price on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $337.10.

Check Out Our Latest Report on Cigna Group

Cigna Group Trading Up 1.1%

Shares of CI stock opened at $274.94 on Wednesday. The firm has a market capitalization of $72.65 billion, a P/E ratio of 11.38, a price-to-earnings-growth ratio of 0.93 and a beta of 0.31. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The firm’s fifty day simple moving average is $279.78 and its 200 day simple moving average is $280.51. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the prior year, the firm earned $7.20 EPS. The business’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts predict that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were paid a dividend of $1.56 per share. The ex-dividend date was Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s payout ratio is currently 25.82%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Everett Neville sold 617 shares of the stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares in the company, valued at $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 22,730 shares of company stock worth $6,293,359. 0.60% of the stock is owned by insiders.

Cigna Group Company Profile

(Get Free Report)

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.